U.S. Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By End-use (Medical Use, Recreational Use), By Cultivation (Indoor, Outdoor), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Source
                       1.2.2. Derivatives
                       1.2.3. End Use
                   1.3. Estimates and Forecast Timeline
                   1.4. Research Methodology
                   1.5. Information Procurement
                       1.5.1. Purchased Database
                       1.5.2. GVR’s Internal Database
                       1.5.3. Secondary Sources
                       1.5.4. Primary Research
                   1.6. Information Analysis
                       1.6.1. Data Analysis Models
                   1.7. Market Formulation & Data Visualization
                   1.8. Model Details
                       1.8.1. Commodity Flow Analysis
                   1.9. List of Secondary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                       2.2.1. Source outlook
                       2.2.2. Derivatives outlook
                       2.2.3. End Use outlook
                   2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Cannabis Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
                           3.2.1.2. Impending legalization of marijuana for recreational/adult use
                           3.2.1.3. Rising number of research studies on cannabis for various ailments
                           3.2.1.4. Growing legalization and awareness of cannabis in various states in the U.S.
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. High cost of cannabis and CBD-based products
                           3.2.2.2. lack of consistency in advertising policies regarding cannabis
                       3.2.3. Case Study Analysis
                   3.3. Business Environment Analysis
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTLE Analysis
                   3.4. Regulatory Landscape
Chapter 4. U.S. Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
                   4.1. Definition and Scope
                   4.2. Source Segment Dashboard
                   4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   4.4. Hemp
                       4.4.1. Hemp Market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.2. Hemp oil
                           4.4.2.1. Hemp Oil Market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.4.3. Industrial Hemp
                           4.4.3.1. Industrial Hemp Market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.5. Marijuana
                           4.5.1.1. Marijuana Market estimates and forecasts, 2018 to 2030, (USD Million)
                       4.5.2. Flower
                           4.5.2.1. Flower Market estimates and forecasts, 2018 to 2030 (USD Million)
                       4.5.3. Oil and Tinctures
                           4.5.3.1. Oil and Tinctures Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. U.S. Cannabis Market Segment Analysis, By Derivative, 2018 - 2030 (USD Million)
                   5.1. Definition and Scope
                   5.2. Derivatives Segment Dashboard
                   5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   5.4. CBD
                       5.4.1. CBD Market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.5. THC
                       5.5.1. THC Market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.6. Others
                       5.6.1. Others Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. U.S. Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)
                   6.1. Definition and Scope
                   6.2. Cultivation Segment Dashboard
                   6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   6.4. Indoor Cultivation
                       6.4.1. Indoor Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.5. Greenhouse Cultivation
                       6.5.1. Greenhouse Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.6. Outdoor Cultivation
                       6.6.1. Outdoor Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. U.S. Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
                   7.1. Definition and Scope
                   7.2. End Use Segment Dashboard
                   7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   7.4. Industrial
                       7.4.1. Industrial Market estimates and forecasts, 2018 to 2030 (USD Million)
                   7.5. Medical
                       7.5.1. Medical Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.2. Chronic Pain
                           7.5.2.1. Chronic Pain Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.3. Depression and Anxiety
                           7.5.3.1. Depression and Anxiety Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.4. Arthritis
                           7.5.4.1. Arthritis Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.5. Post Traumatic Stress Disorder (PTSD)
                           7.5.5.1. Post Traumatic Stress Disorder (PTSD) Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.6. Cancer
                           7.5.6.1. Cancer Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.7. Migraines
                           7.5.7.1. Migraines Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.8. Epilepsy
                           7.5.8.1. Epilepsy Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.9. Alzheimer’s Disease
                           7.5.9.1. Alzheimer’s Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.10. Multiple Sclerosis
                           7.5.10.1. Multiple Sclerosis Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.11. Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis
                           7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.12. Tourette’s Syndrome
                           7.5.12.1. Tourette’s Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.13. Diabetes
                           7.5.13.1. Diabetes Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.14. Parkinson's Disease
                           7.5.14.1. Parkinson's Disease Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.15. Glaucoma
                           7.5.15.1. Glaucoma Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.16. AIDS
                           7.5.16.1. AIDS Market estimates and forecasts, 2018 to 2030 (USD Million)
                       7.5.17. Others
                           7.5.17.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                   7.6. Recreational
                      7.6.1. Recreational Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, by Key Market Participants
                   8.2. Company Categorization
                   8.3. Company Market Position Analysis
                   8.4. Company Profiles
                       8.4.1. Tilray Brands
                           8.4.1.1. Overview
                           8.4.1.2. Financial Performance
                           8.4.1.3. Service Benchmarking
                           8.4.1.4. Strategic Initiatives
                       8.4.2. Canopy Growth Corporation
                           8.4.2.1. Overview
                           8.4.2.2. Financial Performance
                           8.4.2.3. Service Benchmarking
                           8.4.2.4. Strategic Initiatives
                       8.4.3. Medical Marijuana, Inc.
                           8.4.3.1. Overview
                           8.4.3.2. Financial Performance
                           8.4.3.3. Service Benchmarking
                           8.4.3.4. Strategic Initiatives
                       8.4.4. NuLeaf Naturals, LLC
                           8.4.4.1. Overview
                           8.4.4.2. Financial Performance
                           8.4.4.3. Service Benchmarking
                           8.4.4.4. Strategic Initiatives
                       8.4.5. CV Sciences, Inc.
                           8.4.5.1. Overview
                           8.4.5.2. Financial Performance
                           8.4.5.3. Service Benchmarking
                           8.4.5.4. Strategic Initiatives
                       8.4.6. CHARLOTTE’S WEB.
                           8.4.6.1. Overview
                           8.4.6.2. Financial Performance
                           8.4.6.3. Service Benchmarking
                           8.4.6.4. Strategic Initiatives
                       8.4.7. The Cronos Group
                           8.4.7.1. Overview
                           8.4.7.2. Financial Performance
                           8.4.7.3. Service Benchmarking
                           8.4.7.4. Strategic Initiatives
                       8.4.8. Organigram Holding, Inc
                           8.4.8.1. Overview
                           8.4.8.2. Financial Performance
                           8.4.8.3. Service Benchmarking
                           8.4.8.4. Strategic Initiatives
                       8.4.9. Irwin Naturals
                           8.4.9.1. Overview
                           8.4.9.2. Financial Performance
                           8.4.9.3. Service Benchmarking
                           8.4.9.4. Strategic Initiatives
                       8.4.10. Aurora Cannabis
                           8.4.10.1. Overview
                           8.4.10.2. Financial Performance
                           8.4.10.3. Service Benchmarking
                           8.4.10.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. cannabis market, by source, 2018 - 2030 (USD Million)
Table 4. U.S. cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5. U.S. cannabis market, by End Use, 2018 - 2030 (USD Million)
Table 6. U.S. cannabis market, by cultivation, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 U.S. cannabis market: market outlook
Fig. 9 U.S. cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 U.S. cannabis market driver impact
Fig. 14 U.S. cannabis market restraint impact
Fig. 15 U.S. cannabis market strategic initiatives analysis
Fig. 16 U.S. cannabis market: Source movement analysis
Fig. 17 U.S. cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 U.S. cannabis market: Derivatives movement analysis
Fig. 25 U.S. cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 U.S. cannabis market: Cultivation movement analysis
Fig. 30 U.S. cannabis market: Cultivation outlook and key takeaways
Fig. 31 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 33 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 34 U.S. cannabis market: End Use movement analysis
Fig. 35 U.S. cannabis market: End Use outlook and key takeaways
Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 41 Post-Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 45 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 49 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 53 Others market estimates and forecasts, 2018 - 2030
Fig. 54 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 55 Key company categorization